Alector to host fourth quarter and full-year 2024 earnings conference call

South san francisco, calif., feb. 19, 2025 (globe newswire) -- alector, inc. (nasdaq: alec), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced it will host a conference call and webcast on wednesday, february 26, 2025, at 4:30 p.m.
ALEC Ratings Summary
ALEC Quant Ranking